Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
18,632,401
Share change
-591,017
Total reported value
$703,886,639
Put/Call ratio
34%
Price per share
$37.78
Number of holders
161
Value change
-$18,569,388
Number of buys
63
Number of sells
82

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2021

As of 31 Dec 2021, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 161 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,632,401 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, STATE STREET CORP, Bellevue Group AG, BAKER BROS. ADVISORS LP, IRIDIAN ASSET MANAGEMENT LLC/CT, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 161 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.